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Abstract
In vitro culture of hematopoietic stem and progenitor cells (HPCs) is supported by a suitable cellular microenvironment,
such as mesenchymal stromal cells (MSCs)—but MSCs are heterogeneous and poorly defined. In this study, we analyzed
whether MSCs derived from induced pluripotent stem cells (iPS-MSCs) provide a suitable cellular feeder layer too. iPS-
MSCs clearly supported proliferation of HPCs, maintenance of a primitive immunophenotype (CD34+, CD133+, CD38-),
and colony-forming unit (CFU) potential of CD34+ HPCs. However, particularly long-term culture-initiating cell (LTC-IC)
frequency was lower with iPS-MSCs as compared to primary MSCs. Relevant genes for cell-cell interaction were overall
expressed at similar level in MSCs and iPS-MSCs, whereas VCAM1 was less expressed in the latter. In conclusion, our iPS-
MSCs support in vitro culture of HPCs; however, under the current differentiation and culture conditions, they are less
suitable than primary MSCs from bone marrow.
We followed the hypothesis that iPS-MSCs might pro-
vide an unlimited and more standardized alternative to
primary MSCs for stromal support of hematopoietic
stem and progenitor cells (HPCs). To this end, we have
reprogrammed bone marrow-derived MSCs into iPSCs and
subsequently re-differentiated them towards iPS-MSCs as
described before [1]. iPS-MSCs revealed similar fibroblas-
toid morphology, immunophenotype, and in vitro differen-
tiation potential as primary MSCs (Additional file 1). HPCs
were isolated from cord blood after written consent (Ethic
Committee of RWTH Aachen: EK187/08). CD34+ cells
were stained with carboxyfluorescein succinimidyl ester
(CFSE) to monitor cell proliferation [2]. Flow cytometric
analysis of residual CFSE staining after 5 days demonstrated
that HPCs proliferated significantly faster if cultured with
stromal support of either MSCs or iPS-MSCs (Fig. 1a).
CD34 expression declined within a few cell divisions with-
out feeder layer, whereas it was largely maintained over five
subsequent cell divisions under both co-culture conditions
(Fig. 1b). Overall, the expression of CD34 and CD133 de-
clines after five cell divisions, which is consistent with pre-
vious observations [2]. Statistical analysis of CD34, CD38,
CD45, and CD133 expression in relation to the cell div-
ision numbers indicated that co-culture with primary
MSCs was slightly advantageous as compared to iPS-
MSCs for maintenance of a primitive hematopoietic
immunophenotype (Fig. 1c).
We assessed the CFU frequency in freshly isolated HPCs
or upon culture-expansion for 7 days: without stromal sup-
port, there was no expansion of CFUs, whereas CFU
frequency was significantly increased under co-culture con-
ditions with MSCs or iPS-MSCs (Fig. 1d). CFU frequency
was not significantly affected if HPCs were co-cultured
either with MSCs or iPS-MSCs, and there was no bias
towards specific types of colonies (Fig. 1d). However, if
HPCs were cultured for 5 weeks in a long-term
culture-initiating cell (LTC-IC) assay [2], different
hematopoiesis supporting capacities of MSCs and iPS-
MSCs became evident: long-term culture of HPCs
gave rise to a significantly higher number of colonies
on MSCs compared to iPS-MSCs (Fig. 1e).
There is evidence that besides cytokine secretion, dir-
ect cell-cell interaction between HPCs and MSCs is
crucial for the hematopoiesis supportive function and
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migration [3–5]—and this is reflected by cellular
polarization [6, 7]. In fact, co-culture with MSCs gave
rise to a significantly higher fraction of elongated cells
as compared to iPS-MSCs or feeder-free conditions
(Fig. 2a). Subsequently, we reanalyzed previously pub-
lished gene expression profiles of MSCs, iPSCs, and
Fig. 1 The hematopoietic supportive function of iPS-MSCs. a CD34+ cells were stained with CFSE and cultured with or without feeder cells for 5 days.
Co-culture of HPCs with either MSCs or iPS-MSCs enhanced the number of cell divisions significantly (**P < 0.01; ***P < 0.001; n = 5—each with three
biological replicates for MSCs and iPS-MSCs; MFI =mean fluorescence intensity). b Dot plots show CD34 expression in relation to the number of cell
divisions (as a reference we used additional measurements at day 0; the number of cell divisions in different CFSE-gates is indicated). c We gated for
specific cell division numbers and analyzed the signal intensity of CD34, CD133, CD45, and CD38 as compared to culture without feeder layer (gray).
Co-culture with MSCs (red) or iPS-MSCs (blue) led to an increase of CD34 and CD133 expression and a decrease of CD45 expression in proliferating
cells (without feeder vs. MSCs: *P < 0.05, **P < 0.01; without feeder vs. iPS-MSCs: #P < 0.05, ##P < 0.01; MSCs vs. iPS-MSCs : §P < 0.05; n = 5—each with
three biological replicates for MSCs and iPS-MSCs). d CFU frequency was significantly increased by co-culture with either MSCs or iPS-MSCs (**P < 0.01,
n = 3—each with three biological replicates for MSCs and iPS-MSCs). There was no significant bias for specific types of colonies. BFU-E = burst-forming-
unit erythroid; CFU-E = colony-forming-unit erythroid; CFU-G = colony-forming-unit granulocyte; CFU-M = colony-forming-unit macrophage; CFU-GM=
colony-forming-unit granulocyte, macrophage; CFU-GEMM= colony-forming-unit granulocyte, erythrocyte, macrophage, megakaryocyte. e Frequency
of long-term culture initiating cells (LTC-IC) was significantly higher in co-culture with primary bone marrow-derived MSCs as compared to iPS-MSCs or
without stromal support (*P< 0.05, **P< 0.01, ***P< 0.001, n= 3—each with three biological replicates for MSCs and iPS-MSCs). Mean ± S.D. is depicted
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iPS-MSCs (GSE46019, GSE38806, and GSE54766) [1]
with focus on a set of genes that has been considered
to be functionally relevant for cell-cell interaction [8].
Overall, these genes were expressed at very similar
levels in MSCs and iPS-MSCs, underlining the close
molecular relationship of both cell preparations
(Fig. 2b). Among the selected genes, only laminin β1
(LAMB1) was higher expressed in iPS-MSCs (limma
adjusted P value: P = 0.004), and the vascular cell adhe-
sion molecule 1 (VCAM1; CD106) was higher
expressed in MSCs (P = 0.0018). This trend was also
observed by flow cytometric analysis of VCAM1
(Fig. 2c), although it was only expressed in a relatively
small subset of MSCs. We have previously demon-
strated that VCAM1 is higher expressed in bone
marrow-derived MSCs than in adipose tissue-derived
MSCs [9]. Furthermore, we have shown that siRNA-
mediated knockdown of VCAM1 in MSCs entails lower
proliferation rates of co-cultured HPCs [2]. It has been
suggested that VCAM1 positive and negative subsets of
MSCs differ in their biological function [10, 11] and
that particularly the VCAM1 positive subset has higher
immunoregulatory potential [11]. Lower expression of
VCAM1 in iPS-MSCs might therefore be one reason
Fig. 2 Differences in cell-cell interaction with different feeder layers. a The percentage of HPCs with elongated morphology was scored as described
before [6]. Particularly, co-culture with MSCs stimulated cellular elongation (*P < 0.05, n = 3—each with three biological replicates for MSCs and iPS-
MSCs). b Gene expression of relevant genes for cellular interaction with HPCs were analyzed in MSCs, iPSCs, and iPS-MSCs. Overall, all genes were
expressed at very similar levels in primary MSCs and iPS-MSCs—except for Laminin β1 (LAMB1; higher expressed in iPS-MSCs; **P < 0.01) and vascular
cell adhesion molecule 1 (VCAM1; higher expressed in MSCs; **P < 0.01). c Mean fluorescence intensity of VCAM1 (CD106) expression in flow cytometric
analysis (three biological replicates for MSCs and iPS-MSCs). Mean ± S.D. is depicted
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for reduced stromal support. On the other hand, N-
cadherin (CDH2), which is also relevant for inter-
action of MSCs with HSCs [5], was in tendency higher
expressed in iPS-MSCs than MSCs. Notably, differen-
tial expression of LAMB1, VCAM1, and CDH2 was
also reflected in DNA methylation patterns of MSCs
and iPS-MSCs (Additional file 2). Either way, it is
likely that a combination of adhesion proteins and
chemokines evokes the differences in hematopoiesis
supportive potential.
Taken together, our iPS-MSCs provide a less
hematopoiesis supportive microenvironment than pri-
mary MSCs, particularly after long-term co-culture.
This tendency was not observed in a recent study by
Moslem et al. [12], but these authors did not test for
maintenance of LTC-ICs. It is conceivable that opti-
mized differentiation procedures of iPSCs towards
cellular components of the hematopoietic stem cell
niche as well as 3D-culture systems will further en-
hance stromal support to ultimately facilitate in vitro
expansion of HPCs.
Additional files
Additional file 1: Functional characterization of iPS-MSCs. (A) Phase
contrast images of MSCs and iPS-MSCs: iPS-MSCs revealed similar
fibroblastoid morphology as MSCs. (B) iPS-MSCs displayed similar
immunophenotypic characteristics as primary MSCs (MFI = mean
fluorescence intensity; mean ± S.D. of three biological replicates is
presented; *P < 0.05, **P < 0.01). (C) MSCs and iPS-MSCs were differentiated
for three weeks towards adipogenic, osteogenic, and chondrogenic
lineages and subsequently stained with BODIPY/DAPI, Alizarin Red, or
Alcian Blue/PAS, respectively (in analogy to our previous work [1]).
Controls were simultaneously cultured in normal growth medium
(DMEM supplemented with 10 % human platelet lysate). Representative
images are shown. (PDF 153 kb)
Additional file 2: DNA methylation is in line with differential expression
of VCAM1, CDH2, and LAMB1. DNA methylation levels of CpG dinucleotides
in the genes VCAM1, CDH2, and LAMB1 were analyzed for bone
marrow-derived MSCs, iPS-MSCs, and iPSCs using the Illumina 450 k
BeadChip data (GSE17448 and GSE54767) as described in detail in our previ-
ous work [1]. DNA methylation level is given as β-value ranging from 0 (no
methylation) to 1 (100 % methylation). Genomic location of the re-
spective CpG sites and statistical significance of MSCs vs. iPS-MSCs are
indicated (*P < 0.05, **P < 0.01, ***P < 0.001, TSS1500 = 1500 bp upstream of
transcription start site; TSS200 = 200 bp upstream of TSS; UTR = untranslated
region). DNA methylation of VCAM1 was higher in iPS-MSCs than MSCs. In
contrast, close to the transcription start site of LAMB1 and CDH2 several
CpGs revealed significantly lower DNA methylation in iPS-MSCs than
primary MSCs. These epigenetic differences may therefore be relevant
for the observed differences in gene expression. (PDF 362 kb)
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